Tecentriq 1 200 mg concentrate for solution for infusion
Phase 2 small_molecule active
Quick answer
Tecentriq 1 200 mg concentrate for solution for infusion for Muscle-invasive bladder cancer is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Muscle-invasive bladder cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active